LONDON (Reuters) - A new arthritis drug made by Merck & Co. causes fewer stomach disorders and complications than an older painkiller, researchers said on Friday. They analyzed the results of three clinical trials to assess the safety of Merck’s drug etoricoxib -- sold under the name Arcoxia -- as compared with diclofenac.>>> Discuss This Story
